Nandrolone Decanoate
Official Indications For Prescription September, 2002

In the USA:
Approved Use:
"Indicated for the management of the anemia of renal insufficiency
and has been shown to increase hemoglobin and red cell mass."

In Australia:
Approved Use:
"In Osteoporosis where other therapy is inappropriate OR patients
on long term treatment with corticosteroids."

Also listed as an Orphan Drug in Australia:
"Indication: for patients who have proven HIV infection who have
lost at least 5% of their usual body weight."

Nelson says, "It appears that Australia is more progressive than the USA in
approving indications for nandrolone that are more helpful to
those of us who are experiencing certain HIV side-effects,
such as bone loss and weight loss."